Varian Biopharmaceuticals, A Precision Oncology Company, to Present at...

Varian Biopharmaceuticals, Inc. (“VarianBio”), a private, precision oncology company developing novel therapeutics for the treatment of cancer, today announced its President and CEO, Jeffrey Davis,...(PRWeb November 17, 2021)Read the full story at https://www.prweb.com/releases/varian_biopharmaceuticals_a_precision_oncology_company_to_present_at_inflection_partners_excellence_in_execution_conference_on_november_16_17/prweb18335365.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news